Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.

Autor: Tromp, J, Steggink, LC, Van Veldhuisen, DJ, Gietema, JA, van der Meer, P

Publikováno v: Clinical Pharmacology & Therapeutics; Apr2017, Vol. 101 Issue 4, p481-490, 10p

Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors: A Cross-Sectional Study.

Autor: Naaktgeboren WR; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Groen WG; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands., Jacobse JN; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands., Steggink LC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Walenkamp AME; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Harten WH; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands.; Rijnstate Hospital, Arnhem, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands., Stuiver MM; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands.; Center for Quality of Life, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Centre of Expertise Urban Vitality, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands., Aaronson NK; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schaapveld M; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., van Leeuwen FE; The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Amsterdam, the Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2022 Apr 19; Vol. 4 (2), pp. 183-191. Date of Electronic Publication: 2022 Apr 19 (Print Publication: 2022).

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.

Autor: Stelwagen J; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Lubberts S; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Steggink LC; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Steursma G; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Kruyt LM; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Donkerbroek JW; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van Roon AM; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van Gessel AI; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., van de Zande SC; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Meijer C; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Gräfin Zu Eulenburg CH; Department of Epidemiology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Oosting SF; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Nuver J; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Walenkamp AME; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Jan de Jong I; Department of Urology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Lefrandt JD; Department of Internal Medicine, division of Vascular Medicine, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands., Gietema JA; Department of Medical Oncology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands. j.a.gietema@umcg.nl.

Publikováno v: British journal of cancer [Br J Cancer] 2020 Nov; Vol. 123 (11), pp. 1599-1607. Date of Electronic Publication: 2020 Sep 14.

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.

Autor: Steenbruggen TG; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Steggink LC; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Seynaeve CM; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., van der Hoeven JJM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Jager A; Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Konings IR; Department of Medical Oncology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Smit WM; Department of Internal Medicine/Medical Oncology, Medisch Spectrum Twente, Enschede, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., van der Wall E; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Bins AD; Department of Medical Oncology, Amsterdam UMC, location AMC, Amsterdam, the Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Schaapveld M; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Jacobse JN; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., van Leeuwen FE; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., van Tinteren H; Department of Biostatistics, the Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.

Publikováno v: JAMA oncology [JAMA Oncol] 2020 Apr 01; Vol. 6 (4), pp. 528-534.

Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.

Autor: Steggink LC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Beek AP; Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Boer H; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Meijer C; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lubberts S; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Oosting SF; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Jong IJ; Department of Urology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Ginkel RJ; Division of Surgical Oncology, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lefrandt JD; Division of Vascular Medicine, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Gietema JA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Nuver J; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Publikováno v: Andrology [Andrology] 2019 Jul; Vol. 7 (4), pp. 441-448. Date of Electronic Publication: 2019 Jan 04.